Home › NDC Lookup › RxCUI directory › RxCUI 1000064

Doxepin 150 MG Oral Capsule — RxCUI 1000064

RxNorm drug concept · Semantic clinical drug
RxCUI 1000064 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1000064
Official nameDoxepin 150 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdoxepin (as doxepin HCl) 150 MG Oral Capsule; doxepin HCl 150 MG Oral Capsule
FDA products mapped3
Package NDCs mapped7
Reported Medicaid activity (SDUD)29,510 prescriptions · 44 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Doxepin Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • You're right that doxepin is also used as an antidepressant in pill form, but this cream version is completely different — it's applied to the skin specifically to relieve moderate...
  • What exactly is this cream for? My doctor said it's for itching but it's usually an antidepressant — that seems strange.
  • That's one of the most important things to know about this cream. Doxepin is absorbed through your skin into your bloodstream, and it can reach levels high enough to cause real dro...
  • Why does the cream make me so sleepy? I didn't expect that from something I'm putting on my skin.
📖 Read our full Doxepin Topical guide →

🕸️ Concept Web — How Doxepin 150 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Doxepin 150 MG Oral Capsule RxCUI 1000064

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Doxepin 3638
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Doxepin Oral Capsule 371962
    • Doxepin Oral Product 1160768
    • Doxepin Pill 1160769
    • Oral Capsule 316965
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Doxepin 150 MG 2599255

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Doxepin 150 MG SCDC · 2599255
  • Doxepin Oral Capsule SCDF · 371962
  • Doxepin Oral Product SCDG · 1160768
  • Doxepin Pill SCDG · 1160769

📦 FDA Products & Package NDCs

3 products · 7 package NDCs
7 package NDCs map to RxCUI 1000064 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
49884-0222-01 100 CAPSULE in 1 BOTTLE (49884-222-01) Doxepin Hydrochloride Endo USA, Inc. 1987-11-09
49884-0222-03 50 CAPSULE in 1 BOTTLE (49884-222-03) Doxepin Hydrochloride Endo USA, Inc. 1987-11-09
49884-0222-05 500 CAPSULE in 1 BOTTLE (49884-222-05) Doxepin Hydrochloride Endo USA, Inc. 1987-11-09
69315-0163-01 100 CAPSULE in 1 PACKAGE (69315-163-01) DOXEPIN HYDROCHLORIDE Leading Pharma, LLC 2021-04-15
69315-0163-05 500 CAPSULE in 1 PACKAGE (69315-163-05) DOXEPIN HYDROCHLORIDE Leading Pharma, LLC 2021-04-15
69315-0163-50 50 CAPSULE in 1 PACKAGE (69315-163-50) DOXEPIN HYDROCHLORIDE Leading Pharma, LLC 2021-04-15
70518-0386-01 30 CAPSULE in 1 BLISTER PACK (70518-0386-1) Doxepin Hydrochloride REMEDYREPACK INC. 2023-09-11
Observed labelers: Endo USA, Inc. (3) · Leading Pharma, LLC (3) · REMEDYREPACK INC. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.4964
Range $0.4964–$0.5095 · middle 50% $0.4964–$0.5095 · 5 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.